biotech / news / / Devdiscourse
Australia's Monash IVF has turned down a takeover offer from a consortium valuing the fertility service provider at A$350.7 million.
Monash IVF rejected a A$350.7 million takeover bid from a consortium including Genesis Capital.
KEY POINTS
- President Trump ordered the FDA to expedite review of psychedelic drugs like ibogaine for medical use.
- Rat poison contamination was found in HiPP baby food at 1,500 Austrian SPAR supermarkets, triggering a recall.
- Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, with milestone payments possible.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →